• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

West Pharmaceutical Services debuts new needle syringe system

July 1, 2022 By Sean Whooley

West Pharmaceutical Services Daikyo Crystal Zenith Insert Needle Syringe System
[Image from West Pharmaceutical Services]
West Pharmaceutical Services (NYSE:WST) announced the recent unveiling of its Daikyo Crystal Zenith needle syringe system.

Exton, Pennsylvania–based West designed the Daikyo Crystal Zenith 2.25mL insert needle syringe system as a technologically advanced cyclic olefin polymer containment and delivery system. It’s meant to offer an alternative to glass, mitigating the risk of breakage and reducing the chance of particulates, contamination and extractables.

The platform expands upon the 1mL insert needle syringe system, allowing for larger volume injections. According to a news release, as market traction on larger dose injections grows, the new CZ syringe system size will help pharmaceutical companies to bring their product to patients in a safe and most user-centric model possible.

West partnered with Daikyo in an exclusive distributor arrangement to provide the CZ Insert Needle Syringe Systems syringe globally.

“By creating a larger fill volume in our high-quality CZ insert needle syringe system, we’re able to answer the needs of more patients with a safe and reliable containment solution,” West VP and GM of Biologics Li Chen said in the release. “Where patients previously may have needed multiple injections to achieve their dose, the 2.25mL insert needle syringe system will allow for fewer or less frequent injections enabling an easier patient experience.”

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: West Pharmaceutical, West Pharmaceutical Services

IN CASE YOU MISSED IT

  • Senseonics stock is up on Q2 results
  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS